(Q39872458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Cigdem Erten

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Harika Atmaca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Gurbuz Gorumlu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Selim Uzunoglu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Bulent Karabulut

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ulus A Sanli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Yuksel Kucukzeybek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ercument Cengiz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Mustafa K Gul

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

14 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

Molecular Biology Reports

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

1269-1277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review

23 January 2020

cites work

1 reference

12 December 2020

Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance

1 reference

12 December 2020

Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray

1 reference

12 December 2020

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

12 December 2020

Minireview: Cyclin D1: normal and abnormal functions

1 reference

12 December 2020

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

1 reference

12 December 2020

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

12 December 2020

Drug methylation in cancer therapy: lessons from the TPMT polymorphism

1 reference

12 December 2020

Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network phase III trial

1 reference

12 December 2020

Docetaxel (taxotere) in the treatment of prostate cancer

1 reference

12 December 2020

Daily oral estramustine and intermittent intravenous docetaxel (Taxotere) as chemotherapeutic treatment for metastatic, hormone-refractory prostate cancer.

1 reference

12 December 2020

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

12 December 2020

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

12 December 2020

Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease

1 reference

12 December 2020

Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivo

1 reference

12 December 2020

P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation

1 reference

12 December 2020

Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa

1 reference

12 December 2020

Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia

1 reference

12 December 2020

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

12 December 2020

Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.

1 reference

12 December 2020

Cyclin D1 as a target for chemoprevention

1 reference

12 December 2020

BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins

1 reference

12 December 2020

Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways

1 reference

12 December 2020

Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel

1 reference

12 December 2020

A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.

1 reference

12 December 2020

The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer

1 reference

12 December 2020

Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis

1 reference

12 December 2020

Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line

1 reference

12 December 2020

Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas

1 reference

12 December 2020

Estramustine potentiates taxane in prostate and refractory breast cancers

1 reference

12 December 2020

(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer

1 reference

12 December 2020

10.1007/S11033-009-9501-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19288219%20AND%20SRC:MED&resulttype=core&format=json